Price
CHART BY
Frequently asked questions
What is Amneal's market capitalization?
What is the Earnings Per Share (EPS) for Amneal?
What are the analyst ratings and target price for Amneal's stock?
What is Amneal's revenue over the trailing twelve months?
What is the EBITDA for Amneal?
What is the free cash flow of Amneal?
How many employees does Amneal have, and what sector and industry does it belong to?
What is the free float of Amneal's shares?
Financials
- Market Cap
- $2.41B
- EPS (TTM)
- -$0.685
- Free Float
- 126.70M
- Revenue (TTM)
- $2.68B
- EBITDA (TTM)
- $571.20M
- Free Cashflow (TTM)
- $101.30M
Pricing
- 52W span
- $5.01$9.47
Analyst Ratings
The price target is $10.50 and the stock is covered by 4 analysts.
Buy
3
Hold
1
Sell
0
Information
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
- Employees
- 7,850
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US03168L1052
- Primary Ticker
- AMRX